Cilostazol Related Compound C (50 mg) (1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one) , 0.95 , 865792-18-3

Synonym(s):
1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone

CAS NO.：865792-18-3

Empirical Formula: C31H45N9O2

Molecular Weight: 575.75

MDL number: MFCD26142865

PRODUCT Properties

• Melting point: 43 - 47*C
• storage temp.: Refrigerator, under inert atmosphere
• solubility: DMSO (Slightly), Methanol (Slightly)
• color: White to Pale Yellow
• InChIKey: GVMLJEUDNKNZAH-UHFFFAOYSA-N
• SMILES: N1(CCCCC2N(C3CCCCC3)N=NN=2)C2=C(C=C(OCCCCC3N(C4CCCCC4)N=NN=3)C=C2)CCC1=O

Description and Uses

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-3,4-dihydro-2(1H)-quinolinone, is an impurity of Cilostazol (C441500), a potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake.

Safety

• HS Code: 2933790002